David Geraint Owen

Title: David Geraint Owen: Innovator in Potassium Channel Modulation

Introduction

David Geraint Owen is a notable inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly in the area of potassium channel modulation. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

David Geraint Owen holds a patent for "Potassium channel modulators." This invention concerns peptides that possess intracellular potassium channel modulating activity, specifically comprising the amino acid sequence shown in SEQ ID No: 2. His innovative approach to modulating potassium channels could lead to advancements in therapeutic treatments.

Career Highlights

Owen is associated with John Wyeth & Brother Limited, where he has been able to apply his expertise in biochemistry. His role at the company has allowed him to focus on developing new solutions that address critical health challenges. With a patent to his name, he has established himself as a key figure in his field.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Roger Crossley and Albert Opalko. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions.

Conclusion

David Geraint Owen's contributions to potassium channel modulation highlight the vital role of inventors in advancing medical science. His work not only reflects his dedication to innovation but also underscores the collaborative nature of scientific research.